EU approves post-chemo option for patients with ovarian cancer

22nd November 2017 Uncategorised 0

European regulators have cleared Tesaro’s Zejula, offering a new option for the maintenance treatment of certain adults with platinum-sensitive relapsed high grade serous epithelial ovarian, fallopian tube, or primary peritoneal cancer.

More: EU approves post-chemo option for patients with ovarian cancer
Source: News